Evidence map›Paper›PMID 37686724›Full record

Trial reportNutrients2023

Eicosapentaenoic Acid and Medium-Chain Triacylglycerol Structured Lipids Improve Endurance Performance.

Katsunori Tsuji, Yosuke Tsuchiya, Kaori Yokoi, Kenichi Yanagimoto, Hisashi Ueda, Eisuke Ochi

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Katsunori TsujiSports Research Center, Hosei University, Kawasaki 211-0065, Japan.
Yosuke TsuchiyaCenter for Liberal Arts, Laboratory of Health and Sports Sciences, Meiji Gakuin University, Yokohama 244-8539, Japan.
Kaori YokoiFood Function R&D Center, Nissui Corporation, Tokyo 105-8676, Japan.
Kenichi YanagimotoFood Function R&D Center, Nissui Corporation, Tokyo 105-8676, Japan.
Hisashi UedaFaculty of Health and Medical Science, Department of Medical Sports, Teikyo Heisei University, Ichihara 290-0193, Japan.
Eisuke OchiSports Research Center, Hosei University, Kawasaki 211-0065, Japan.ORCID 0000-0002-2497-0250
Hosei University · JPNippon Suisan Kaisha (Japan) · JPMeiji Gakuin University · JPTeikyo Heisei University · JP

Funding

Nippon Suisan Kaisha (Japan) NA
6 · The paper itself

Abstract

purposeThe effects of intake of STGs containing esterified eicosapentaenoic acid (EPA) and medium-chain triglycerides (MCTs) on cardiorespiratory endurance have not yet been reported. This study aimed to examine the efficacy of interesterified structured lipids EPA and MCTs on cardiorespiratory endurance.

methodsThis 8-week randomized double-blind placebo-controlled parallel-group study involved 19 healthy men. The participants were randomly assigned to a group that received interesterified structured lipids EPA and MCTs (STG group, 9 participants) or a group receiving a PM of EPA and MCTs (PM group, 10 participants). The outcome measures were time to exhaustion (TTE) and time to reach the anaerobic threshold in the peak oxygen uptake (VO

resultsThe increase in TTE in the VO

conclusionThis study demonstrated that the consumption of interesterified structured lipids EPA and MCTs improved endurance in humans.

Indexed as

Eicosapentaenoic AcidNutritional StatusAnaerobic ThresholdHealth StatusHumansMaleTriglyceridesEicosapentaenoic AcidTriglycerideseicosapentaenoic acidendurancemedium-chain triacylglycerolsperformancestructured lipids

Identifiers

PMID37686724
PMCPMC10489969
OpenAlexW4386141783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.